Vitamin D Testing
Defines medical necessity criteria, repeat testing intervals, excluded indications, and related coding for serum total vitamin D (25[OH]D; CPT 82306, 0038U) and active vitamin D (1,25[OH]2D; CPT 82652) for Cigna-administered plans effective 2026-06-15. Part 1 covers policy statements, lists of covered diagnoses (ICD-10-CM), repeat testing guidance, and general background/evidence citations.
Revised policy statement indications and frequency of testing.
Revised policy statement on frequency of testing.
Revised frequency policy statement.
No clinical policy statement changes noted in focused reviews.
No clinical policy statement changes noted during annual review on 3/15/2024.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.